跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BUPREDERMAL buprenorphine 15 micrograms/hour transdermal drug delivery system sachet
Approved
STANDARD
BUPREDERMAL buprenorphine 15 micrograms/hour transdermal drug delivery system sachet
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
cee212132944c5c3
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
cee212132944c5c3
Product Name
BUPREDERMAL buprenorphine 15 micrograms/hour transdermal drug delivery system sachet
Artg Id
234743
Artg Name
BUPREDERMAL buprenorphine 15 micrograms/hour transdermal drug delivery system sachet
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2017-09-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/80575ddb981dae9ece6104ebc2dc512a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4f4e1072dfee8ecd1466f771a57dc83f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
cee212132944c5c3
Type
Standard
Back to TGA Approvals
BUPREDERMAL buprenorphine 15 micrograms/hour transdermal drug delivery system sachet - TGA Drug Approval Details